What's new | Periotherapia Co., Ltd.

JP
EN

TOP Company Introduction

Company Introduction

Company Introduction Executive Introduction Company Overview

Executive Introduction Company Overview Research and Development Pipeline What's new Inquiry

JP
EN

News

TOP What’s new

All

Funding-related Clinical Trial Progress Joint Research and Licensing Media Relations Awards and Selections Notices

2026.06.02
Funding-related

First Close of Series D2 Financing Raise…
2026.06.02
Notices

Notice of Head Office Relocation
2026.05.14
Media Relations

An Interview with our CEO, Eiji Tahara, …
2026.03.02
Notices

AMED: Approval Granted for Transition to…
2025.12.12
Notices

Notice of Winter Holiday Closure
2025.12.05
Media Relations

Interview with our CEO Tahara published …
2025.10.15
Awards and Selections

Perioscerapia Inc. Wins Excellence Award…
2025.09.17
Notices

Presentation by Technical Advisor Dr. Ka…
2025.09.09
Notices

We will be exhibiting at the Japan Healt…
2025.08.26
Media Relations

Our Company Highlighted in FUJIFILM Wako…

投稿のページ送り

1 2 3

2026.06.02
Funding-related

First Close of Series D2 Financing Raise…
2026.06.02
Notices

Notice of Head Office Relocation
2026.05.14
Media Relations

An Interview with our CEO, Eiji Tahara, …
2026.03.02
Notices

AMED: Approval Granted for Transition to…
2025.12.12
Notices

Notice of Winter Holiday Closure
2025.12.05
Media Relations

Interview with our CEO Tahara published …
2025.10.15
Awards and Selections

Perioscerapia Inc. Wins Excellence Award…
2025.09.17
Notices

Presentation by Technical Advisor Dr. Ka…
2025.09.09
Notices

We will be exhibiting at the Japan Healt…
2025.08.26
Media Relations

Our Company Highlighted in FUJIFILM Wako…

投稿のページ送り

1 2 3

2026.06.02
Funding-related

First Close of Series D2 Financing Raise…
2026.06.02
Notices

Notice of Head Office Relocation
2026.05.14
Media Relations

An Interview with our CEO, Eiji Tahara, …
2026.03.02
Notices

AMED: Approval Granted for Transition to…
2025.12.12
Notices

Notice of Winter Holiday Closure
2025.12.05
Media Relations

Interview with our CEO Tahara published …
2025.10.15
Awards and Selections

Perioscerapia Inc. Wins Excellence Award…
2025.09.17
Notices

Presentation by Technical Advisor Dr. Ka…
2025.09.09
Notices

We will be exhibiting at the Japan Healt…
2025.08.26
Media Relations

Our Company Highlighted in FUJIFILM Wako…

投稿のページ送り

1 2 3

2026.06.02
Funding-related

First Close of Series D2 Financing Raise…
2026.06.02
Notices

Notice of Head Office Relocation
2026.05.14
Media Relations

An Interview with our CEO, Eiji Tahara, …
2026.03.02
Notices

AMED: Approval Granted for Transition to…
2025.12.12
Notices

Notice of Winter Holiday Closure
2025.12.05
Media Relations

Interview with our CEO Tahara published …
2025.10.15
Awards and Selections

Perioscerapia Inc. Wins Excellence Award…
2025.09.17
Notices

Presentation by Technical Advisor Dr. Ka…
2025.09.09
Notices

We will be exhibiting at the Japan Healt…
2025.08.26
Media Relations

Our Company Highlighted in FUJIFILM Wako…

投稿のページ送り

1 2 3

2026.06.02
Funding-related

First Close of Series D2 Financing Raise…
2026.06.02
Notices

Notice of Head Office Relocation
2026.05.14
Media Relations

An Interview with our CEO, Eiji Tahara, …
2026.03.02
Notices

AMED: Approval Granted for Transition to…
2025.12.12
Notices

Notice of Winter Holiday Closure
2025.12.05
Media Relations

Interview with our CEO Tahara published …
2025.10.15
Awards and Selections

Perioscerapia Inc. Wins Excellence Award…
2025.09.17
Notices

Presentation by Technical Advisor Dr. Ka…
2025.09.09
Notices

We will be exhibiting at the Japan Healt…
2025.08.26
Media Relations

Our Company Highlighted in FUJIFILM Wako…

投稿のページ送り

1 2 3

2026.06.02
Funding-related

First Close of Series D2 Financing Raise…
2026.06.02
Notices

Notice of Head Office Relocation
2026.05.14
Media Relations

An Interview with our CEO, Eiji Tahara, …
2026.03.02
Notices

AMED: Approval Granted for Transition to…
2025.12.12
Notices

Notice of Winter Holiday Closure
2025.12.05
Media Relations

Interview with our CEO Tahara published …
2025.10.15
Awards and Selections

Perioscerapia Inc. Wins Excellence Award…
2025.09.17
Notices

Presentation by Technical Advisor Dr. Ka…
2025.09.09
Notices

We will be exhibiting at the Japan Healt…
2025.08.26
Media Relations

Our Company Highlighted in FUJIFILM Wako…

投稿のページ送り

1 2 3

2026.06.02
Funding-related

First Close of Series D2 Financing Raise…
2026.06.02
Notices

Notice of Head Office Relocation
2026.05.14
Media Relations

An Interview with our CEO, Eiji Tahara, …
2026.03.02
Notices

AMED: Approval Granted for Transition to…
2025.12.12
Notices

Notice of Winter Holiday Closure
2025.12.05
Media Relations

Interview with our CEO Tahara published …
2025.10.15
Awards and Selections

Perioscerapia Inc. Wins Excellence Award…
2025.09.17
Notices

Presentation by Technical Advisor Dr. Ka…
2025.09.09
Notices

We will be exhibiting at the Japan Healt…
2025.08.26
Media Relations

Our Company Highlighted in FUJIFILM Wako…

投稿のページ送り

1 2 3

Contact

For any questions or enquiries,
please contact us here

Contact

Periotherapia Co., Ltd.
2-12-11 Nishinakajima,Yodogawa-ku,Osaka City, Osaka
532-0011
TEL: +81 6-7653-4746
FAX: +81 6-6459-9199

Company Introduction Executive Introduction Company Overview Research and Development Pipeline What's new Inquiry

Copyright © 2024 Periotherapia Co.,Ltd. All Rights Reserved.